Grimes & Company, Inc. I Specimen Inc. Transaction History
Grimes & Company, Inc.
- $3.22 Billion
- Q1 2024
A detailed history of Grimes & Company, Inc. transactions in I Specimen Inc. stock. As of the latest transaction made, Grimes & Company, Inc. holds 30,818 shares of ISPC stock, worth $9,553. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,818
Previous 30,818
-0.0%
Holding current value
$9,553
Previous $15,000
53.33%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ISPC
# of Institutions
12Shares Held
299KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA76.6KShares$23,7320.0% of portfolio
-
Black Rock Inc. New York, NY56.5KShares$17,5260.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny44.1KShares$13,6570.0% of portfolio
-
Geode Capital Management, LLC Boston, MA38.5KShares$11,9340.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY15.2KShares$4,7120.0% of portfolio
About iSpecimen Inc.
- Ticker ISPC
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 8,880,600
- Market Cap $2.75M
- Description
- iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, bioban...